TEHILA SABO: Open Payments
NPI 1518321751 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 7 payments from 6 companies in 2025. Trend: 2023 $899 · 2024 $245 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $254 |
| GENZYME CORPORATION | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $78 |
| Novo Nordisk Inc | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $16 |
Products named: CERDELGA, TZIELD, Rybelsus, TERLIVAZ, TARPEYO.
Industry payments across FL — which companies pay providers there.
